RECORD // Company

Obsidian Therapeutics, Inc.

Formerly: Gazelle Parent, Inc.

Built 2026-11-21T05:45:42Z from public sources · JSON · Open the company profile

ASK THE RECORDS

Ask

COMPANY

Records for this company (1 joined by official identifier)

Every record below is joined to this company by a hard identifier: its SEC registrant record or its GLEIF ownership tree. Each line says how. Built 2026-11-18 13:42:42. Beta: records that match only by name are held apart until name matching is verified.

SEC EDGAR (1)
Matched by name only, not merged (5)

These records carry the same exact name as this company, but a name alone is not proof, so Seraphix holds them apart until name matching is verified (score due 11-21).

  • Obsidian Therapeutics, Inc. · Ctgov · same registered legal name as 'Obsidian Therapeutics, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • OBSIDIAN THERAPEUTICS, INC. · East licences · same registered legal name as 'Obsidian Therapeutics, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • OBSIDIAN THERAPEUTICS, INC. · East licences · same registered legal name as 'Obsidian Therapeutics, Inc.' Possible match based on name, not a shared identifier. Compare the records. Compare
  • OBSIDIAN THERAPEUTICS · Epa echo · exact name match to 'Obsidian Therapeutics, Inc.' (no other entity shares the name) Possible match based on name, not a shared identifier. Compare the records. Compare
  • OBSIDIAN THERAPEUTICS · Epa echo · exact name match to 'Obsidian Therapeutics, Inc.' (no other entity shares the name) Possible match based on name, not a shared identifier. Compare the records. Compare

3 VALUES · 10-Q · EACH LINKS TO ITS FILING

Latest quarter

Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-12 · accession 0001193125-26-458414

ItemValuePeriodFormFiledAccessionReport
Revenue$03 months ended 2026-09-3010-Q2026-11-120001193125-26-4584142026-11-21 05:45 UTCReport an error
Net income (loss)$-50,656,0003 months ended 2026-09-3010-Q2026-11-120001193125-26-4584142026-11-21 05:45 UTCReport an error
Cash and cash equivalents$66,507,000at 2026-09-3010-Q2026-11-120001193125-26-4584142026-11-21 05:45 UTCReport an error

Negative as reported in the filing.

Not in this report's XBRL: Interest expense.

Values as filed in XBRL (SEC company facts); quarterly values are the filer's 3-month figures, never derived.

IDS

Identifiers

SEC CIK
0002130606
Ticker
OBX
EIN
421977778
CUSIP
67448A106
Record ID
sx:sec:0002130606

OTHER SITES · YOUR CLICK · THEY SHOW THEIR OWN DATA

Open in

Open in…

Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.

5 FACTS · EACH LINKS TO ITS FILING

Facts

FactValueAs ofSourceRetrievedReport
SEC entity typeoperating2026-11-16SEC EDGAR company profile2026-11-21 05:45 UTCReport an error
SIC industry2834 Pharmaceutical Preparations2026-11-16SEC EDGAR company profile2026-11-21 05:45 UTCReport an error
Fiscal year end (MMDD)12312026-11-16SEC EDGAR company profile2026-11-21 05:45 UTCReport an error
Business address1030 MASSACHUSETTS AVENUE, CAMBRIDGE, MA, 021382026-11-16SEC EDGAR company profile2026-11-21 05:45 UTCReport an error
ExchangesNasdaq2026-11-16SEC EDGAR company profile2026-11-21 05:45 UTCReport an error

EVERY DATED RECORD, NEWEST FIRST

Timeline

WHAT IS NOT HERE

Gaps

SOURCES AND LICENSE

Sources

CC BY 4.0 -- credit Seraphix Systems.

API

Use this record

Records are free to read and reuse under CC BY 4.0 -- credit Seraphix Systems. The same records as JSON: GET /v1/search?q= and GET /v1/record/<id> (without a key, up to 50 record lookups a day per visitor). No key: single records, pages, feeds and bulk files are free; cross-company search and the live stream cost $0.002 a call via x402. Free key: 100 calls a month, no card. Get a free key or a paid key; send Authorization: Bearer <key>.